All In Biotech

Drug Trial Radar · NCT03191149

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Phase II Study of Osimertinib (AZD9291) in Advanced NSCLC Patients With Exon 20 Insertion Mutations in EGFR

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

46

Planned (sponsor's estimate)

Start

Apr 25, 2018

Primary completion

Jun 30, 2027

Study completion Jun 30, 2027

Sponsor

Sponsor type
NIH
First posted
Jun 19, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Conditions

  • Advanced Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
  • Stage IV Lung Non-Small Cell Cancer AJCC v7

Interventions

  • Biospecimen CollectionProcedure

    Undergo collection of blood samples

  • Computed Tomography with ContrastProcedure

    Undergo CT with contrast

  • Echocardiography TestProcedure

    Undergo ECHO

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • Multigated Acquisition ScanProcedure

    Undergo MUGA

  • OsimertinibDrug

    Given PO

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Best objective responseTime frame: Up to 5 years

Locations

347 sites in 1 country. Site status is shown where the registry gives one.

  • Anchorage Associates in Radiation Medicine

    Anchorage, Alaska · Active not recruiting

  • Anchorage Radiation Therapy Center

    Anchorage, Alaska · Active not recruiting

  • Alaska Breast Care and Surgery LLC

    Anchorage, Alaska · Active not recruiting

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska · Active not recruiting

  • Alaska Women's Cancer Care

    Anchorage, Alaska · Active not recruiting

  • Anchorage Oncology Centre

    Anchorage, Alaska · Active not recruiting

  • Katmai Oncology Group

    Anchorage, Alaska · Active not recruiting

  • Providence Alaska Medical Center

    Anchorage, Alaska · Active not recruiting

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska · Recruiting

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas · Recruiting

  • CARTI Cancer Center

    Little Rock, Arkansas · Recruiting

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California · Active not recruiting

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia · Recruiting

  • Holy Cross Hospital

    Fort Lauderdale, Florida · Recruiting

  • Emory University Hospital Midtown

    Atlanta, Georgia · Recruiting

  • Emory University Hospital/Winship Cancer Institute

    Atlanta, Georgia · Recruiting

  • Emory Saint Joseph's Hospital

    Atlanta, Georgia · Recruiting

  • Saint Alphonsus Cancer Care Center-Boise

    Boise, Idaho · Recruiting

  • Saint Luke's Cancer Institute - Boise

    Boise, Idaho · Active not recruiting

  • Saint Alphonsus Cancer Care Center-Caldwell

    Caldwell, Idaho · Recruiting

  • Kootenai Health - Coeur d'Alene

    Coeur d'Alene, Idaho · Recruiting

  • Walter Knox Memorial Hospital

    Emmett, Idaho · Suspended

  • Saint Luke's Cancer Institute - Fruitland

    Fruitland, Idaho · Active not recruiting

  • Idaho Urologic Institute-Meridian

    Meridian, Idaho · Recruiting

  • Saint Luke's Cancer Institute - Meridian

    Meridian, Idaho · Active not recruiting

  • Saint Alphonsus Cancer Care Center-Nampa

    Nampa, Idaho · Recruiting

  • Saint Luke's Cancer Institute - Nampa

    Nampa, Idaho · Active not recruiting

  • Kootenai Clinic Cancer Services - Post Falls

    Post Falls, Idaho · Recruiting

  • Kootenai Clinic Cancer Services - Sandpoint

    Sandpoint, Idaho · Recruiting

  • Saint Luke's Cancer Institute - Twin Falls

    Twin Falls, Idaho · Active not recruiting

  • OSF Saint Anthony's Health Center

    Alton, Illinois · Recruiting

  • Rush-Copley Medical Center

    Aurora, Illinois · Suspended

  • Illinois CancerCare-Bloomington

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Canton

    Canton, Illinois · Recruiting

  • Memorial Hospital of Carbondale

    Carbondale, Illinois · Recruiting

  • SIH Cancer Institute

    Carterville, Illinois · Recruiting

  • Illinois CancerCare-Carthage

    Carthage, Illinois · Recruiting

  • Centralia Oncology Clinic

    Centralia, Illinois · Recruiting

  • Saint Mary's Hospital

    Centralia, Illinois · Suspended

  • Carle at The Riverfront

    Danville, Illinois · Recruiting

Showing 40 of 347 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.